Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07457125) titled 'The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Xuanwu Hospital, Beijing
Condition:
Mild to Moderate Alzheimer's Disease
Intervention:
Drug: Exosomes derived from umbilical cord mesenchymal stem cell for intranasal drop
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 10, 2026
Target Sample Size: 33
...